AMLX
Asset Logo

AMYLYX PHARMACEUTICALS, INC.

🇺🇸 NYSE/NASDAQ

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-24.64%
Annual Growth

3 years average annual growth

🌏

1
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Amylyx Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in the discovery and development of treatments for neurodegenerative diseases. The Company is focused on the development and commercialization of its product candidate: AMX0035 for the treatment of Wolfram syndrome and for the treatment of progressive supranuclear palsy, and AMX0114, the Company’s antisense oligonucleotide targeting calpain-2 for the treatment of amyotrophic lateral sclerosis (ALS). AMX0035 is a dual-unfolded protein response (UPR)-Bax apoptosis inhibitor composed of PB and TURSO (also known as TUDCA). The Company’s Avexitide is an investigational, first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist that has been evaluated in five clinical trials for post-bariatric hypoglycemia (PBH) and has also been studied in congenital hyperinsulinism (HI), two indications characterized by hyperinsulinemic hypoglycemia.

📈 Performance

Price History*

-69.69%

1M

1Y

All Time

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$5.64

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in AMLX

1

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

4 days

💵 Average investment amount

$264

Last time a customer invested in AMLX

215 days
AMLX investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

100%
👶 Age of investors

18 - 25

26 - 34

100%

35 - 90

🙋 Legal gender of investors

Female

Male

100%

Pearlers who invest in AMLX also invest in...

Alphabet Inc. - Class A Shares

GOOGL

🙌 Performance (5Yr p.a)

1043.13%

📊 Share price

$171.29 USD
Find Out More

📊 Share price

$41.92 USD

🙌 Performance (5Yr p.a)

115.74%

📊 Share price

$74.32 USD

🙌 Performance (5Yr p.a)

-19.74%

📊 Share price

$1.39 USD

📊 Share price

$22.71 USD

Want more shares? Try these...

🙌 Performance (5Yr p.a)

-7.68%

📊 Share price

$36.90 USD

🙌 Performance (5Yr p.a)

1.32%

📊 Share price

$46.48 USD
Compare
Add to watchlist